Additional value of measurement of urinary cortisone and unconjugated cortisol metabolites in assessing the activity of 11β-hydroxysteroid dehydrogenase in vivo

Clinical Endocrinology

Volumn 47, Issue 2, 1997, Pages 231-236

  Best, Ruth ^a   Walker, Brian R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CARBENOXOLONE; CORTISONE; GLYCYRRHIZIC ACID; HYDROCORTISONE;

ADULT; ARTICLE; CONTROLLED STUDY; ELECTROLYTE BALANCE; ENZYME ACTIVITY; GAS CHROMATOGRAPHY; GENE EXPRESSION; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE URINE LEVEL; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; SODIUM BALANCE;

EID: 0030832511     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1997.2471061.x     Document Type: Article

References (32)

1. Agarwal, A.K., Monder, C., Eckstein, B. & White, P.C. (1989) Cloning and expression of rat cDNA encoding corticosteroid 11β-dehydrogenase. Journal of Biological Chemistry, 264, 18939-18943.
2. +-dependent isoform of 11β-hydroxysteroid dehydrogenase. Cloning and characterisation of cDNA from sheep kidney. Journal of Biological Chemistry, 269, 25959-25962.
3. Albiston, A.L., Obeyesekere, V.R., Smith, R.E. & Krozowski, Z.S. (1994) Cloning and tissue distribution of the human 11β-hydroxysteroid dehydrogenase type 2 enzyme. Molecular and Cellular Endocrinology, 105, R11-R17.
4. Best, R., Nelson, S.M. & Walker, B.R. (1997) Dexamethasone and 11-dehydrodexamethasone as tools to investigate the isozymes of 11β-hydroxysteroid dehydrogenase in vitro and in vivo. Journal of Endocrinology, 153, 41-48.
5. Dullart, R.B.F., Ubels, F.L., Hoogenberg, K., Smith, A.J., Pratt, J.J., Muntinga, J.H.J., Sluiter, W.J. & Wolthers, B.G. (1995) Alterations in cortisol metabolism in insulin-dependent diabetes mellitus: relationship with metabolic control and estimated blood volume and effect of angiotensin-converting enzyme inhibition. Journal of Clinical Endocrinology and Metabolism, 80, 3002-3008.
6. Edwards, C.R.W., Burt, D., McIntyre, M.A., De Kloet, E.R., Stewart, P.M., Brett, L., Sutanto, W.S. & Monder, C. (1988) Localisation of 11β-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor. Lancet, 986-989.
7. Edwards, C.R.W. & Walker, B.R. (1993) Cortisol and hypertension: what was not so apparent about 'apparent mineralocorticoid excess'. Journal of Laboratory and Clinical Medicine, 122, 632-635.
8. Funder, J.W., Pearce, P.T., Smith, R. & Smith, A.I. (1988) Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science, 242, 583-585.
9. Hall, J.E., Granger, J.P., Smith, M.J. & Premen, A.J. (1984) Role of renal hemodynamics and arterial pressure in aldosterone 'escape'. Hypertension, 6 (Suppl. 1), I-183-I-192.
10. Lin, C-L., Wu, T-J., Machecek, D.A., Jiang, N.-S. & Kao, P. (1997) Urinary free cortisol and cortisone determined by high performance liquid chromatography in the diagnosis of Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism, 82, 151-155.
11. Mantero, F., Tedde, R., Opocher, G., Fulgheri, P.D., Arnaldi, G. & Ulick, S. (1994) Apparent mineralocorticoid excess Type II. Steroids, 59, 80-83.
12. Mune, T., Rogerson, F.M., Nikkila, H., Agarwal, A.K. & White, P.C. (1995) Human hypertension caused by mutations in the kidney isozyme of 11β-hydroxysteroid dehydrogenase. Nature Genetics, 10, 394-399.
13. Palermo, M., Shackleton, C.H.L., Mantero, F., Stewart, P.M. (1996) Urinary free cortisone and the assessment of 11β-hydroxysteroid dehydrogenase activity in man. Clinical Endocrinology, 45, 605-611.
14. Phillipou, G. & Higgins, B.A. (1985) A new defect in the peripheral conversion of cortisone to cortisol. Journal of Steroid Biochemistry, 22, 435-436.
15. Rodin, A., Thakkar, H., Taylor, N. & Clayton, R. (1994) Hyperandrogenism in polycystic ovary syndrome. Evidence of dysregulation of 11β-hydroxysteroid dehydrogenase. New England Journal of Medicine, 330, 460-465.
16. Shackleton, C.H.L. & Honour, J. (1976) Simultaneous estimation of urinary steroids by semi-quantitative automated gas chromatography. Investigation of neo-natal infants and children with abnormal steroid synthesis. Clinical Chimica Acta, 69, 267-283.
17. Soro, A., Ingram, M.C., Tonolo, G., Glorioso, N. & Fraser, R. (1995) Evidence of coexisting changes in 11β-hydroxysteroid dehydrogenase and 5β-reduclase activity in patients with untreated essential hypertension. Hypertension, 25, 67-70.
18. Stewart, P.M., Valentino, R., Wallace, A.M., Burt, D., Shackleton, C.H.L. & Edwards, C.R.W. (1987) Mineralocorticoid activity of liquorice: 11β-hydroxysteroid dehydrogenase deficiency comes of age. Lancet, ii, 821-824.
19. Stewart, P.M., Wallace, A.M., Atherden, S.M., Shearing, C.H. & Edwards, C.R.W. (1990) Mineralocorticoid activity of carbenoxolone: contrasting effects of carbenoxolone and liquorice on 11β-hydroxysteroid dehydrogenase activity in man. Clinical Science, 78, 49-54.
20. Stewart, P.M., Burra, P., Shackleton, C.H.L., Sheppard, M.C. & Elias, E. (1993) 11β-hydroxysteroid dehydrogenase deficiency and glucocorticoid status in patients with alcoholic and non-alcoholic liver disease. Journal of Clinical Endocrinology and Metabolism, 76, 748-751.
21. Stewart, P.M., Walker, B.R., Holder, G., O'Halloran, D. & Shackleton, C.H.L. (1995) 11β-hydroxysteroid dehydrogenase activity in Cushing's syndrome: explaining the mineralocorticoid excess state of the ectopic ACTH syndrome. Journal of Clinical Endocrinology and Metabolism, 80, 3617-3620.
22. Stewart, P.M., Krozowski, Z.S., Gupta, A., Milford, D.V., Howie, A.J., Sheppard, M.C. & Whorwood, C.B. (1996) Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11β-hydroxysteroid dehydrogenase type 2 gene. Lancet, 347, 88-91.
23. Ulick, S., Wang, J.Z., Blumenfeld, J.D. & Pickering, T.G. (1992) Cortisol inactivation overload: a mechanism of mineralocorticoid hypertension in the ectopic adrenocorticotropin syndrome. Journal of Clinical Endocrinology and Metabolism, 74, 963-967.
24. Walker, B.R., Campbell, J.C., Fraser, R., Stewart, P.M. & Edwards, C.R.W. (1992) Mineralocorticoid excess and inhibition of 11β-hydroxysteroid dehydrogenase in patients with ectopic ACTH syndrome. Clinical Endocrinology, 37, 483-192.
25. +-dependent isoform of 11β-hydroxysteroid dehydrogenase. Endocrinology, 131, 970-972.
26. Walker, B.R., Connacher, A.A., Lindsay, R.M., Webb, D.J. & Edwards, C.R.W. (1995) Carbenoxolone increases hepatic insulin sensitivity in man: a novel role for 11-oxosteroid reductase in enhancing glucocorticoid receptor activation. Journal of Clinical Endocrinology and Metabolism, 80, 3155-3159.
27. Walker, B.R. & Edwards, C.R.W. (1994) Licorice-induced hypertension and syndromes of apparent mineralocorticoid excess. Endocrinology and Metabolism Clinics of North America, 23, 359-377.
28. Walker, B.R., Stewart, P.M., Shackleton, C.H.L., Padfield, P.L. & Edwards, C.R.W. (1993) Deficient inactivation of cortisol by 11β-hydroxysteroid dehydrogenase in essential hypertension. Clinical Endocrinology (Oxford), 39, 221-227.
29. Wilson, R.C., Harbison, M.D., Krozowski, Z.S., Funder, J.W., Shackleton, C.H.L., Hanauske-Abel, H.M., Wei, J.-Q., Hertecant, J., Moran, A., Neiberger, R.E., Balfe, J.W., Fattah, A., Daneman, D., Licholaim, T. & New, M.I. (1995a) Several homozygous mutations in the gene for 11β-hydroxysteroid dehydrogenase type 2 in patients with apparent mineralocorticoid excess. Journal of Clinical Endocrinology and Metabolism, 80, 3145-3150.
30. Wilson, R.C., Krozowski, Z.S., Li, K., Obeyesekere, V.R., Razzaghy-Azar, M., Harbison, M.D., Wei, J.Q., Shackleton, C.H.L., Funder, J.W. & New, M.I. (1995b) A mutation in the HSD11B2 gene in a family with apparent mineralocorticoid excess. Journal of Clinical Endocrinology and Metabolism, 80, 2263-2266.
31. Wood, P.J., Glenn, C. & Donovan, S.J. (1996) A simple RIA for serum cortisone without preliminary steroid chromatography (Abstract). Journal of Endocrinology, 148 (Suppl.), P319.
32. Zumoff, B., Fukushima, D.K. & Hellman, L. (1974) Intercomparison of four methods for measuring cortisol production rate. Journal of Clinical Endocrinology and Metabolism, 38, 169-175.